Rajiv Raman

Dr. Rajiv Raman

Sankara Nethralaya, Chennai, India

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2018 in Eye
Verified
Journal Article
Closed access
PDF file
Rajiv RamanRajiv Raman
Rajiv Raman
SSSangeetha Srinivasan
Sangeetha Srinivasan
SVSunny Virmani
Sunny Virmani
SSSobha Sivaprasad
Sobha Sivaprasad
CRChetan Rao
Chetan Rao
RRRamachandran Rajalakshmi
Ramachandran Rajalakshmi

1 January 2019 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
Rajiv RamanRajiv Raman
Rajiv Raman
SSSumeer Singh
Sumeer Singh
SPShahina Pardhan
Shahina Pardhan
VKVaitheeswaran Kulothungan
Vaitheeswaran Kulothungan
GSGayathri Swaminathan
Gayathri Swaminathan
TSTarun Sharma
Tarun Sharma
Purpose: To report the prevalence and risk factors of cataract and its subtypes in older age group. Methods: A total of 6617 subjects were recruited from both rural and urban areas. A detailed history including data on demographic, socioeconomic and ocular history was obtained. Lens opacity was graded according to the Lens Opacity Classification System III (LOCS III). Results: Cataract was present in 1094 of the rural and 649 subjects in the urban population. Monotype subtype cataracts were found in 32% and 25% in rural and urban population and 12.68% and 18.6% were mixed cataracts in the rural and urban groups. In baseline characteristics history of diabetes, alcohol intake and presence of age-related macular degeneration were the risk factors in urban group. On multivariate analysis, the only significant risk factors for any cataract in subjects ≥60 years were increasing age in both rural [odds ratio (OR), 1.07] and urban (OR, 1.08) population, and HbA1c (OR, 1.14) in rural population. Overweight (OR, 0.6) was found to be a protective factor, and lower social economic status (OR, 1.52) a risk factor for cataract in urban population. A significant urban–rural difference was found in the prevalence of cataract and its subtypes (P ≤ 0.05). Conclusion: We found the risk factors for any cataract in older age group to be increasing age and HbA1c in rural group. Age and lower social economic status were found to be the risk factors in urban arm. A statistically significant difference was found on comparison of the prevalence of cataract and its subtypes between the rural and urban population.

1 January 2016 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
Rajiv RamanRajiv Raman
Rajiv Raman
LGLaxmi Gella
Laxmi Gella
SSSangeetha Srinivasan
Sangeetha Srinivasan
TSTarun Sharma
Tarun Sharma
Prevention of blindness due to diabetic retinopathy (DR) requires effective screening strategies, for which eye care providers need to know the magnitude of the burden and the risk factors pertinent in their geographical location. It is estimated that around 72 million of the global adult population (around 8.2%) has diabetes and about one-fifth of all adults with diabetes lives in the South-East Asia. In India, around 65 million people have diabetes. As the global prevalence of diabetes increases, so will the number of people with diabetes-related complications, such as DR; nearly one-third of them are likely to develop this complication. This article reviews the present status of diabetes and DR in India, the current situation of DR services and the projections on the load of morbidity associated with retinopathy. The article compiles the Indian studies elucidating the risk factors for DR.

1 March 2021 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
Rajiv RamanRajiv Raman
Rajiv Raman
KRKim Ramasamy
Kim Ramasamy
RRRamachandran Rajalakshmi
Ramachandran Rajalakshmi
SSSobha Sivaprasad
Sobha Sivaprasad
SNS Natarajan
S Natarajan
Diabetic retinopathy (DR) is an emerging preventable cause of blindness in India. All India Ophthalmology Society (AIOS) and Vitreo-Retinal Society of India (VRSI) have initiated several measures to improve of DR screening in India. This article is a consensus statement of the AIOS DR task force and VRSI on practical guidelines of DR screening in India. Although there are regional variations in the prevalence of diabetes in India at present, all the States in India should screen their population for diabetes and its complications. The purpose of DR screening is to identify people with sight-threatening DR (STDR) so that they are treated promptly to prevent blindness. This statement provides strategies for the identification of people with diabetes for DR screening, recommends screening intervals in people with diabetes with and without DR, and describes screening models that are feasible in India. The logistics of DR screening emphasizes the need for dynamic referral pathways with feedback mechanisms. It provides the clinical standards required for DR screening and treatment of STDR and addresses the governance and quality assurance (QA) standards for DR screening in Indian settings. Other aspects incorporate education and training, recommendations on Information technology (IT) infrastructure, potential use of artificial intelligence for grading, data capture, and requirements for maintenance of a DR registry. Finally, the recommendations include public awareness and the need to work with diabetologists to control the risk factors so as to have a long-term impact on prevention of diabetes blindness in India.

25 May 2011 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
PRPadmaja Rani
Padmaja Rani
Rajiv RamanRajiv Raman
Rajiv Raman
AGAditi Gupta
Aditi Gupta
SPSwakshyar S Pal
Swakshyar S Pal
VKVaitheeswaran Kulothungan
Vaitheeswaran Kulothungan
TSTarun Sharma
Tarun Sharma
Background: The concordance of microalbuminuria and diabetic retinopathy (DR) has been well reported in persons with type 1 diabetes; however, for type 2 diabetes, there is paucity of data especially from population-based studies. The aim of this study was to estimate the prevalence of albuminuria (micro - and macroalbuminuria) among persons with type 2 diabetes and determine its role as a risk factor for presence and severity of DR. Methods: A population-based cross sectional study was conducted in cohort of 1414 subjects with type 2 diabetes from Chennai metropolis. All the subjects underwent comprehensive eye examination including 45 degrees four-field stereoscopic digital photography. DR was clinically graded using Early Treatment Diabetic Retinopathy Study scales. A morning urine sample was tested for albuminuria. Subjects were considered to have microalbuminuria, if the urinary albumin excretion was between 30 and 300 mg/24 hours, and macroalbuminuria at more than 300 mg/24 hours. The statistical software used was SPSS for Windows, Chicago, IL. Student t-test for comparing continuous variables, and χ 2 test, to compare proportions amongst groups were used. Results: The prevalence of microalbuminuria in the study subjects was 15.9% (226/1414), and that of macroalbuminuria, 2.7% (38/1414). Individuals with macroalbuminuria in comparison to micro- or normoalbuminuria showed a greater prevalence of DR (60.5% vs. 31.0% vs. 14.1%, p < 0.001), and also a greater severity of the disease (60.9% vs. 21.4 vs. 9.9, p < 0.001). Conclusions: Every 6th individual in the population of type 2 diabetes is likely to have albuminuria. Subjects with microalbuminuria were around 2 times as likely to have DR as those without microalbuminuria, and this risk became almost 6 times in the presence of macroalbuminuria.

26 October 2023 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
SSSerena Sunkari
Serena Sunkari
ASAshish Sangam
Ashish Sangam
VPVenkata Sreeram P.
Venkata Sreeram P.
SMSuchetha M.
Suchetha M.
Rajiv RamanRajiv Raman
Rajiv Raman
TSTamilselvi S.
Tamilselvi S.